
Lipophosphonoxins The Next Generation Antibiotics?
Antimicrobial resistance poses an increasing threat, demanding innovative therapeutic strategies. Lipophosphonoxins (LpxNs) are emerging as promising broad-spectrum antibacterial agents that target LpxC, an essential enzyme in bacterial lipid A synthesis, circumventing common resistance mechanisms.





